Showing results (461-470 of 626) with videos related to
Sort By:
Pageof 63
Cancers|February 15, 2022
Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder CancerStephanie N Shishido, Salmaan Sayeed, George Courcoubetis, et al.Cancer Research|August 3, 2002
A molecular role for lysyl oxidase in breast cancer invasionDawn A Kirschmann, Elisabeth A Seftor, Sheri F T Fong, et al.British Journal of Haematology|June 15, 2005
SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factorArmando V Mena-Duran, Summanuna H Togo, Lyudmila Bazhenova, et al.Scientific Reports|March 3, 2019
Intracellular delivery of mRNA to human primary T cells with microfluidic vortex sheddingJustin A Jarrell, Amy A Twite, Katherine H W J Lau, et al.Scientific Reports|September 22, 2019
The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune responseLeonardo Josué Castro-Muñoz, Joaquín Manzo-Merino, J Omar Muñoz-Bello, et al.The Journal of Rheumatology|February 7, 1998
Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell populationZ Khalkhali-Ellis, E A Seftor, D R Nieva, et al.Geroscience|March 13, 2025
Polypharmacy and its association with dementia, Parkinson's disease, and mortality risk in UK adults: a multistate modeling approachJordan Weiss, May A Beydoun, Michael F Georgescu, et al.Therapeutic Advances in Medical Oncology|March 5, 2026
Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitorsRobert Hsu, Karen Resnick, Peter Zang, et al.Ciencia & Saude Coletiva|June 4, 2025
Gender-based violence against women: a scoping reviewSheyla Christine Santos Fernandes, Marcikele Nascimento Martins, Samyra Araújo Ferro Rocha, et al.Oncology|May 11, 2012
A pilot study of long-acting octreotide for symptomatic malignant ascitesAminah Jatoi, Jorge J Nieva, Rui Qin, et al.Pageof 63